BREA, Calif. (February 4, 2024) – Beckman Coulter,
Inc. has obtained full distribution rights of CellaVision digital
morphology products in the U.S. Under an agreement with CellaVision
AB, Beckman Coulter – the leader in hematology and clinical
diagnostic systems – will distribute the full line of
CellaVision products, including analyzers for automation of the
manual blood differential, an optional application for body fluid
analysis, software applications for remote access and networking,
and software for proficiency testing and education.
"Our agreement with CellaVision will make digital morphology
more available to medium and large labs that perhaps didn’t
have access to this technology before," said Cynthia Collins, group
vice president Cellular Analysis at Beckman Coulter. "And, of
course, digital morphology is a terrific enhancement to our award
winning automated hematology solutions, including the UniCel DxH
800 Coulter Cellular Analysis system."
Trends in North America indicate that in addition to large
laboratories, medium-sized laboratories also have the need to
automate the analytical process in order to improve efficiencies
and quality of the manual differential review.
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify,
automate and innovate complex biomedical tests. More than
200,000 Beckman Coulter systems operate in laboratories around the
world, supplying critical information for improving patient health
and reducing the cost of care. Recurring revenue, consisting of
consumable supplies (including reagent test kits), service and
operating-type lease payments, represent about 78% of the company's
2008 revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.
About CellaVision
CellaVision AB develops, markets, and sells market leading
image analysis based systems for routine analysis of blood and
other body fluids. The company has a core competence in development
of software and hardware for automatic image analysis of cells and
cell changes for applications in health and medical care. The
company develops and markets systems for automatic differentials of
white blood cells and red morphology, and software for education
and quality assurance of differentials.
Beckman Coulter, the stylized logo, UniCel and Coulter are
registered trademarks of Beckman Coulter, Inc.
SOURCE